Bioqual Share Holder Equity 2012-2025 | BIOQ
Bioqual share holder equity from 2012 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
|
Bioqual Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2025 | $36 |
| 2024 | $38 |
| 2023 | $38 |
| 2022 | $38 |
| 2021 | $34 |
| 2020 | $28 |
| 2019 | $25 |
| 2018 | $22 |
| 2017 | |
| 2016 | |
| 2015 | |
| 2013 | |
| 2012 | |
| 2011 | |
|
Bioqual Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2025-08-31 | $36 |
| 2025-05-31 | $36 |
| 2025-02-28 | $36 |
| 2024-11-30 | $35 |
| 2024-08-31 | $37 |
| 2024-05-31 | $38 |
| 2024-02-29 | $39 |
| 2023-11-30 | $39 |
| 2023-08-31 | $39 |
| 2023-05-31 | $38 |
| 2023-02-28 | $38 |
| 2022-11-30 | $39 |
| 2022-08-31 | $39 |
| 2022-05-31 | $38 |
| 2022-02-28 | $36 |
| 2021-11-30 | $35 |
| 2021-08-31 | $35 |
| 2021-05-31 | $34 |
| 2021-02-28 | $31 |
| 2020-11-30 | $30 |
| 2020-08-31 | $30 |
| 2020-05-31 | $28 |
| 2020-02-29 | $27 |
| 2019-11-30 | $26 |
| 2019-08-31 | $0 |
| 2019-05-31 | $25 |
| 2019-02-28 | $0 |
| 2018-11-30 | $0 |
| 2018-08-31 | |
| 2018-05-31 | $22 |
| 2018-02-28 | |
| 2017-11-30 | |
| 2017-08-31 | |
| 2017-05-31 | |
| 2017-02-28 | |
| 2016-11-30 | |
| 2016-08-31 | |
| 2016-05-31 | |
| 2016-02-29 | |
| 2015-11-30 | |
| 2015-08-31 | |
| 2015-05-31 | |
| 2015-02-28 | |
| 2014-08-31 | |
| 2014-05-31 | |
| 2013-11-30 | |
| 2013-08-31 | |
| 2013-05-31 | |
| 2012-05-31 | |
| 2012-02-29 | |
| 2011-11-30 | |
| 2011-08-31 | |
| 2011-05-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.034B | $0.049B |
| BIOQUAL, Inc., formerly Diagnon Corporation, develops, produces and sells diagnostic test kits incorporating monoclonal antibodies to diagnose certain anemias, infections, and parasitic diseases. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $34.042B | 17.17 |
| Quest Diagnostics (DGX) | United States | $23.013B | 21.00 |
| Elanco Animal Health (ELAN) | United States | $12.486B | 26.18 |
| Encompass Health (EHC) | United States | $11.082B | 20.17 |
| DaVita (DVA) | United States | $9.950B | 13.72 |
| Chemed (CHE) | United States | $6.703B | 23.54 |
| Option Care Health (OPCH) | United States | $5.622B | 23.93 |
| RadNet (RDNT) | United States | $5.365B | 183.00 |
| LifeStance Health (LFST) | United States | $2.735B | 0.00 |
| Addus HomeCare (ADUS) | United States | $2.103B | 21.72 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.657B | 20.87 |
| U.S Physical Therapy (USPH) | United States | $1.322B | 33.44 |
| Pennant (PNTG) | United States | $1.106B | 36.75 |
| Astrana Health (ASTH) | United States | $1.057B | 98.84 |
| Daxor (DXR) | United States | $0.062B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.038B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |